Is CCCC a good stock to buy? C4 Therapeutics, Inc. (NASDAQ: CCCC) was in 20 hedge funds' portfolios at the end of March. The all time high for this statistic is 22. CCCC investors should pay attention ...

C4 Therapeutics, Inc. (CCCC) has been on a downward spiral lately with significant selling pressure. After declining 26.2% over the past four weeks, the stock looks well positioned for a trend ...

CCCC Lisbon 2025 shifted from spectacle to production, with creators using AI, refining influence, and building real Web3 strategy.

C4 Therapeutics Inc. Annual stock financials by MarketWatch. View the latest CCCC financial statements, income statements and financial ratios.

As of September 13, 2025, the average one-year price target for C4 Therapeutics is $14.79/share. The forecasts range from a low of $3.03 to a high of $52.50. The average price target represents an ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Destination dining, but make it as approachable as it is astounding. That’s what this laidback, leafy-green Singapore newcomer promises in the form of a six-part Chef’s Choice dinner that shakes up ...

MANILA, Philippines — State-owned China Communications Construction Co. Ltd. (CCCC) has again expressed its interest in developing the Sangley Point International Airport (SPIA) project in Cavite ...

Kuwait will sign a contract next week with China Communications Construction Company (CCCC) to complete the Mubarak Al-Kabeer ...